March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the more ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 20, 2018 — When patients who had a heart attack were given vouchers to cover their co-payments for medication to ...
March 20, 2018 — Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke ...
March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...
March 20, 2018 — African-American men who received medical intervention aimed at controlling their high blood pressure w ...
March 19, 2018 — The combined rate of death from any cause, heart attack or stroke within 18 months was not ...
March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to ...
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...
March 14, 2018 — After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker ...
March 14, 2018 — Breast cancer patients who started taking one of two well-known heart medications at the same time they ...
March 13, 2018 – Among patients with persistently high cholesterol despite high-intensity statin therapy, the ...
February 19, 2018 — A late-breaking analysis of the landmark COMPASS study was presented at the 2018 International ...
February 13, 2018 — Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual ...
February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the National ...
January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of ...